World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
76
Citations
26620
World Ranking
1393
National Ranking
609

Medicine

D-Index
77
Citations
27504
World Ranking
18296
National Ranking
9127

Ronald J. Bosch publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Ronald J. Bosch sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 269 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Ronald J. Bosch D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Ronald J. Bosch sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Ronald J. Bosch is affiliated with Harvard University in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a significant concentration in Infectious Diseases and Virology as key subfields. Emergency Medicine, Epidemiology, and Immunology also feature among their areas of study.

The scientist's work centers on several major topics, including HIV Research and Treatment, HIV/AIDS Research and Interventions, and HIV/AIDS drug development and treatment. Additional topics include HIV-related health complications and treatments, immune cell function and interaction, hepatitis C virus research, and cytomegalovirus and herpesvirus research.

Recent publications authored or co-authored by Ronald J. Bosch demonstrate involvement in research related to viral infections and immune response. Notable papers include:

  • SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis (2020), published in EBioMedicine
  • Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy (2020), published in The Journal of Infectious Diseases
  • Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy (2023), published in Cell Host & Microbe
  • Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies (2021), published in Clinical Infectious Diseases
  • CD4/CD8 Ratio and Cancer Risk Among Adults With HIV (2022), published in JNCI Journal of the National Cancer Institute

Ronald J. Bosch has collaborated frequently with several other researchers, often contributing together on topics related to infectious diseases and HIV/AIDS. Frequent co-authors include Joseph J. Eron, Richard D. Moore, Rajesh T. Gandhi, John W. Mellors, and Mari M. Kitahata.

The publishing venues where Ronald J. Bosch's work appears most frequently include UNC Libraries, The Journal of Infectious Diseases, Clinical Infectious Diseases, bioRxiv (Cold Spring Harbor Laboratory), and AIDS. These venues reflect a strong presence in infectious disease and HIV-related research communities.

Best Publications

  • The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

    P. A. Kern;Mehrnoosh Saghizadeh;J. M. Ong;R. J. Bosch

  • Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

    Hasina Samji;Angela Cescon;Robert S. Hogg;Robert S. Hogg;Sharada P. Modur

  • Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman

  • Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

    N. M. Archin;A. L. Liberty;A. D. Kashuba;S. K. Choudhary

  • The prevalence and incidence of neurocognitive impairment in the HAART era.

    Kevin R. Robertson;Marlene Smurzynski;Thomas D. Parsons;Kunling Wu

  • Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

    Ginger Lehrman;Ian B Hogue;Sarah Palmer;Cheryl Jennings

  • Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies

    Susanne Eriksson;Erin H. Graf;Viktor Dahl;Matthew C. Strain

  • Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1

    Angela Meier;J Judy Chang;Ellen S Chan;Richard B Pollard

  • Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment

    Allan R. Tenorio;Yu Zheng;Ronald J. Bosch;Supriya Krishnan

  • Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

    Michael J. Silverberg;Bryan Lau;Amy C. Justice;Amy C. Justice;Eric Engels

  • Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

    Amanda M. Crooks;Rosalie Bateson;Anna B. Cope;Noelle P. Dahl

  • Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

    Benigno Rodríguez;Ajay K. Sethi;Vinay K. Cheruvu;Wilma Mackay

  • Influence of HLA-C Expression Level on HIV Control

    Richard Apps;Richard Apps;Ying Qi;Ying Qi;Jonathan M. Carlson;Haoyan Chen;Haoyan Chen

  • The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

    Rajesh T. Gandhi;Lu Zheng;Ronald J. Bosch;Ellen S. Chan

  • Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy

    Anthony R. Cillo;Michele D. Sobolewski;Ronald J. Bosch;Elizabeth Fyne

  • The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption

    Jonathan Z. Li;Behzad Etemad;Hayat Ahmed;Evgenia Aga

  • Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression.

    Loyda Ylisastigui;Nancie M Archin;Ginger Lehrman;Ronald J Bosch

  • Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.

    Hernan Valdez;Elizabeth Connick;Elizabeth Connick;Kimberly Y. Smith;Kimberly Y. Smith;Michael M. Lederman

  • Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.

    Marlene Smurzynski;Kunling Wu;Scott Letendre;Kevin Robertson

  • Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.

    Alison G. Abraham;Gypsyamber D'Souza;Yuezhou Jing;Stephen J. Gange

  • Late Presentation for Human Immunodeficiency Virus Care in the United States and Canada

    Keri N. Althoff;Stephen J. Gange;Marina B. Klein;John T. Brooks

Frequent Co-Authors

Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Rajesh T. Gandhi
Rajesh T. Gandhi Harvard University
Wafaie W. Fawzi
Wafaie W. Fawzi Harvard University
Christopher Duggan
Christopher Duggan Boston Children's Hospital
Ann C. Collier
Ann C. Collier University of Washington
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
John W. Mellors
John W. Mellors University of Pittsburgh
Richard D. Moore
Richard D. Moore Johns Hopkins University
Amy C. Justice
Amy C. Justice Yale University
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens numerous career opportunities, often complemented by related online programs. For those interested in healthcare, understanding what medical degree can I get online helps explore flexible options that combine lab work with patient care roles.

Public health is another closely linked field, with many students considering an online Master of Public Health (MPH). If accessibility is a concern, reviewing which online mph programs are easiest to get into can guide applicants toward programs that offer a more straightforward admission process without compromising quality.

Career paths like becoming a certified child life specialist often require additional certifications but provide meaningful work directly impacting children’s wellbeing. Knowing the certified child life specialist salary and job demands can assist students in deciding if this path complements their microbiology background.

For those facing unique challenges, including individuals with criminal records, it’s encouraging to note that several programs are designed to be inclusive. Looking at the best associate degrees for felons may reveal online options that help overcome barriers and launch successful careers.

Best Scientists Citing Ronald J. Bosch

Trending Scientists